This biopharma firm targets rare diseases with both approved therapies and a pipeline of clinical-stage treatments.

Travere Therapeutics Inc. (NASDAQ:TVTX) is one of the best mid-cap growth stocks to buy right now. On January 14, Bank of ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

The Food and Drug Administration has extended the review period for sparsentan in focal segmental glomerulosclerosis (FSGS).

Investing.com -- HBM Healthcare Investments (SIX: HBMN) on Friday reported a quarterly profit of CHF 191 million in the third quarter, bringing nine-month earnings to CHF 286 million despite currency ...

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.